Stocks
Axsome Therapeutics (AXSM) OCF US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| OCF, bln rub | ? | -108.2 | -116.5 | -145.1 | -128.4 | -93.4 | -70.7 | ||
| Changes by years, y/y, % | +38% | +8% | +25% | -11% | -27% | +3.5% | |||
Axsome Therapeutics. OCF, bln rub
Axsome Therapeutics. OCF, changes, %
Axsome Therapeutics. OCF, sum by quarters, bln rub
Axsome Therapeutics (AXSM) OCF US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| OCF, bln rub | ? | -32.4 | 1.05 | -18.7 | -20.7 | -33.0 | -70.7 | |
| Changes by years, y/y, % | +8% | -106% | -29% | -52% | +2% | |||
| Changes by quarters, q/q, % | -25% | -103% | -1 883% | +11% | +59% | |||
